Trial Profile
Drug Use Investigation for Arepanrix (H1N1)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 03 Mar 2014 New trial record